HighTide Therapeutics Inc (2511.HK)

HKD 1.11

(14.43%)

Revenue Summary of HighTide Therapeutics Inc

  • HighTide Therapeutics Inc's latest annual revenue in 2023 was - CNY , down 0.0% from previous year.
  • HighTide Therapeutics Inc's latest quarterly revenue in 2024 Q2 was - HKD , down 0.0% from previous quarter.
  • HighTide Therapeutics Inc reported a annual revenue of - CNY in annual revenue 2022, down 0.0% from previous year.
  • HighTide Therapeutics Inc reported a annual revenue of - CNY in annual revenue 2021, down 0.0% from previous year.
  • HighTide Therapeutics Inc reported a quarterly revenue of - HKD for 2024 Q1, down 0.0% from previous quarter.
  • HighTide Therapeutics Inc reported a quarterly revenue of - HKD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of HighTide Therapeutics Inc (2023 - 2021)

Historical Annual Revenue of HighTide Therapeutics Inc (2023 - 2021)

Year Revenue Revenue Growth
2023 - CNY 0.0%
2022 - CNY 0.0%
2021 - CNY 0.0%

Peer Revenue Comparison of HighTide Therapeutics Inc

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 100.0%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 100.0%